{"id":"placebo-matched-to-rifampin","safety":{"commonSideEffects":[{"rate":"null","effect":"Hepatotoxicity"},{"rate":"null","effect":"Thrombocytopenia"},{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Vomiting"},{"rate":"10-20%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL374478","moleculeType":"Small molecule","molecularWeight":"822.95"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Rifampin works by binding to the beta subunit of bacterial RNA polymerase, thereby inhibiting RNA synthesis and ultimately leading to the death of the bacterial cell. This results in a decrease in the bacterial load and a reduction in the severity of symptoms associated with bacterial infections.","oneSentence":"Rifampin is a bacterial RNA polymerase inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:48.353Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of tuberculosis"},{"name":"Prophylaxis of meningococcal meningitis"}]},"trialDetails":[{"nctId":"NCT03012529","phase":"PHASE4","title":"Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2018-01-22","conditions":"Osteomyelitis, Diabetes, Amputation","enrollment":843},{"nctId":"NCT05822544","phase":"PHASE1","title":"Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes","status":"RECRUITING","sponsor":"OrsoBio, Inc","startDate":"2023-04-22","conditions":"Healthy Subjects, Obesity, Type 2 Diabetes","enrollment":564},{"nctId":"NCT04493931","phase":"PHASE1","title":"Drug-drug Interaction Study of Gepotidacin","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2020-08-14","conditions":"Infections, Bacterial","enrollment":64},{"nctId":"NCT04142762","phase":"PHASE1","title":"A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults","status":"COMPLETED","sponsor":"Assembly Biosciences","startDate":"2019-10-18","conditions":"Chronic Hepatitis B","enrollment":80},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT00439166","phase":"PHASE3","title":"Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2007-02","conditions":"Alzheimer's Disease","enrollment":100},{"nctId":"NCT01215851","phase":"PHASE2","title":"Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)","status":"COMPLETED","sponsor":"Global Alliance for TB Drug Development","startDate":"2010-10","conditions":"Pulmonary Tuberculosis","enrollment":85},{"nctId":"NCT00715858","phase":"PHASE3","title":"A Pilot Study of Inflammatory Markers in Alzheimer's Disease","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2008-05","conditions":"Alzheimer's Disease","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo matched to Rifampin","genericName":"Placebo matched to Rifampin","companyName":"Hamilton Health Sciences Corporation","companyId":"hamilton-health-sciences-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rifampin is a bacterial RNA polymerase inhibitor. Used for Treatment of tuberculosis, Prophylaxis of meningococcal meningitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}